Full Press Release Details
eylea aflibercept injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity rop by the fda.
REGN
eylea aflibercept injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity rop by the fda
Key Takeaway: eylea aflibercept injection approved as the first pharmacologic treatment for preterm infants with retinopathy of prematurity rop by the fda